69 related articles for article (PubMed ID: 24136016)
1. Appropriate modulation of autophagy sensitizes malignant peripheral nerve sheath tumor cells to treatment with imatinib mesylate.
Okano M; Sakata N; Ueda S; Takemura T
J Pediatr Hematol Oncol; 2014 Apr; 36(3):200-11. PubMed ID: 24136016
[TBL] [Abstract][Full Text] [Related]
2. Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein.
Elzinga BM; Nyhan MJ; Crowley LC; O'Donovan TR; Cahill MR; McKenna SL
Am J Hematol; 2013 Jun; 88(6):455-62. PubMed ID: 23440701
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.
Shingu T; Fujiwara K; Bögler O; Akiyama Y; Moritake K; Shinojima N; Tamada Y; Yokoyama T; Kondo S
Int J Cancer; 2009 Mar; 124(5):1060-71. PubMed ID: 19048625
[TBL] [Abstract][Full Text] [Related]
4. Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells.
Can G; Ekiz HA; Baran Y
Hematology; 2011 Mar; 16(2):95-9. PubMed ID: 21418740
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence.
Drullion C; Trégoat C; Lagarde V; Tan S; Gioia R; Priault M; Djavaheri-Mergny M; Brisson A; Auberger P; Mahon FX; Pasquet JM
Cell Death Dis; 2012 Aug; 3(8):e373. PubMed ID: 22898871
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.
Ohishi J; Aoki M; Nabeshima K; Suzumiya J; Takeuchi T; Ogose A; Hakozaki M; Yamashita Y; Iwasaki H
BMC Cancer; 2013 May; 13():224. PubMed ID: 23642185
[TBL] [Abstract][Full Text] [Related]
7. Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells.
Li C; Liu Y; Liu H; Zhang W; Shen C; Cho K; Chen X; Peng F; Bi Y; Hou X; Yang Z; Zheng Z; Wang K; Wang X; Zhang J; Zhong C; Zou H; Zhang X; Zhao S
Cell Physiol Biochem; 2015; 35(4):1303-16. PubMed ID: 25721868
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.
Aoki M; Nabeshima K; Koga K; Hamasaki M; Suzumiya J; Tamura K; Iwasaki H
Lab Invest; 2007 Aug; 87(8):767-79. PubMed ID: 17558420
[TBL] [Abstract][Full Text] [Related]
9. [Autophagy in hematologic malignancies].
Adachi S
Rinsho Ketsueki; 2009 Oct; 50(10):1531-8. PubMed ID: 19915363
[No Abstract] [Full Text] [Related]
10. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
Zheng B; Zhu H; Gu D; Pan X; Qian L; Xue B; Yang D; Zhou J; Shan Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):234-239. PubMed ID: 25712526
[TBL] [Abstract][Full Text] [Related]
11. Autophagy and the functional roles of Atg5 and beclin-1 in the anti-tumor effects of 3beta androstene 17alpha diol neuro-steroid on malignant glioma cells.
Graf MR; Jia W; Johnson RS; Dent P; Mitchell C; Loria RM
J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):137-45. PubMed ID: 19375507
[TBL] [Abstract][Full Text] [Related]
12. GDC-0980-induced apoptosis is enhanced by autophagy inhibition in human pancreatic cancer cells.
Tang JY; Dai T; Zhang H; Xiong WJ; Xu MZ; Wang XJ; Tang QH; Chen B; Xu M
Biochem Biophys Res Commun; 2014 Oct; 453(3):533-8. PubMed ID: 25285629
[TBL] [Abstract][Full Text] [Related]
13. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway.
Li Y; Luo P; Wang J; Dai J; Yang X; Wu H; Yang B; He Q
Toxicol Appl Pharmacol; 2014 Jan; 274(2):319-27. PubMed ID: 24321340
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells.
Shen Y; Ren X; Ding K; Zhang Z; Wang D; Pan J
Oncotarget; 2014 Nov; 5(21):10407-20. PubMed ID: 25431951
[TBL] [Abstract][Full Text] [Related]
15. Modulation of imatinib cytotoxicity by selenite in HCT116 colorectal cancer cells.
Abdel-Aziz AK; Azab SS; Youssef SS; El-Sayed AM; El-Demerdash E; Shouman S
Basic Clin Pharmacol Toxicol; 2015 Jan; 116(1):37-46. PubMed ID: 24930392
[TBL] [Abstract][Full Text] [Related]
16. Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.
Patwardhan PP; Surriga O; Beckman MJ; de Stanchina E; Dematteo RP; Tap WD; Schwartz GK
Clin Cancer Res; 2014 Jun; 20(12):3146-58. PubMed ID: 24718867
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
[TBL] [Abstract][Full Text] [Related]
18. Induction of endoplasmic reticulum stress-mediated apoptosis and non-canonical autophagy by luteolin in NCI-H460 lung carcinoma cells.
Park SH; Park HS; Lee JH; Chi GY; Kim GY; Moon SK; Chang YC; Hyun JW; Kim WJ; Choi YH
Food Chem Toxicol; 2013 Jun; 56():100-9. PubMed ID: 23454208
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effect of imatinib mesylate in non-BCR-ABL-expressing cells along with autophagosome formation.
Ohtomo T; Miyazawa K; Naito M; Moriya S; Kuroda M; Itoh M; Tomoda A
Biochem Biophys Res Commun; 2010 Jan; 391(1):310-5. PubMed ID: 19912986
[TBL] [Abstract][Full Text] [Related]
20. Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer.
Rao AS; Kremenevskaja N; von Wasielewski R; Jakubcakova V; Kant S; Resch J; Brabant G
J Clin Endocrinol Metab; 2006 Jan; 91(1):159-68. PubMed ID: 16263821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
